Background. Routine administration of Health Related Quality of Life (HRQoL) and needs assessment instruments has been advocated as part of clinical care to aid the recognition of psychosocial problems, to inform clinical decision making, to monitor therapeutic response and to facilitate patient-doctor communication. However, their adoption is not without cost and the benefit of their use is unclear. Method. A systematic review was conducted. We sought experimental studies that examined the addition of routinely administered measures of HRQoL to care in both psychiatric and nonpsychiatric settings. We searched the following databases : MEDLINE, EMBASE, CINAHL, PsycLIT and Cochrane Controlled Trials Register (to 2000). Data were extracted independently and a narrative synthesis of results was presented. Results. Nine randomized and quasi-randomized studies conducted in non-psychiatric settings were found. All the instruments used included an assessment of mental well-being, with specific questions relating to depression and anxiety. The routine feedback of these instruments had little impact on the recognition of mental disorders or on longer term psychosocial functioning. While clinicians welcomed the information these instruments imparted, their results were rarely incorporated into routine clinical decision making. No studies were found that examined the value of routine assessment and feedback of HRQoL or patient needs in specialist psychiatric care settings. Conclusions. Routine HRQoL measurement is a costly exercise and there is no robust evidence to suggest that it is of benefit in improving psychosocial outcomes of patients managed in nonpsychiatric settings. Major policy initiatives to increase the routine collection and use of outcome measures in psychiatric settings are unevaluated.
INTRODUCTION

Routine outcome measurement
The measurement of patient outcome has risen in prominence over the past 30 years (Donabedian, 1966 ; Ellwood, 1988 ; Lohr, 1988) . Instruments have been developed that measure symp-cognitive capacity ; and, patient satisfaction (Ware, 1995) . A related development has been the emergence of standardized needs assessment tools, which measure unmet emotional, physical, social and financial needs of the individual patient -including those with mental illness (National Institute of Mental Health, 1987 ; Thornicroft et al. 1992 ; Brewin & Wing, 1993 ; Johnson et al. 1996) .
Outcomes measures and needs assessment tools are now used for a number of purposes, including : the evaluation of the clinical and cost effectiveness of interventions ; the monitoring of population health ; clinical audit ; service planning ; quality improvement ; and, as an aid to clinical decision making in routine clinical practice (Faden & Leplege, 1992 ; Fitzpatrick et al. 1992 ; Fitzpatrick, 1994 ; Ware, 1995 ; Johnson et al. 1996) . It is the last of these uses that will be considered in this review.
The potential benefits of routine HRQoL and needs assessment
When used as aids to individual patient decisionmaking in routine care, HRQoL measures and needs assessment tools may potentially improve individual patient care in a number of ways. First, they help in identifying problems that might not otherwise be recognized. For example, clinicians are often unaware of a patient's social and psychological problems (Sprangers & Aaranson, 1992) , the identification of which might lead to improvement of the overall quality and outcome of patient care (Kazis et al. 1990 ; Young & Chamberlain, 1987) . Secondly, standardized measurement of the patients' progress over time may help the clinician to make informed decisions about treatment and to assess the impact of treatment changes. Thirdly, patients often welcome the opportunity of giving clinicians information about their health status, particularly when they perceive this information is not otherwise comprehensively assessed, thus improving satisfaction with patient-doctor communication (Nelson et al. 1990) .
In this study we are interested in two areas in which routine HRQoL and needs assessment might be particularly useful. The first is in the recognition and management of psychiatric disorders (such as anxiety and depression) in non-psychiatric settings (such as primary care and the general hospital). The second is in the management of already recognized psychiatric disorders in specialist psychiatric care settings.
Disorders such as anxiety and depression are common in primary care and general hospital settings, and yet often go unrecognized (Goldberg & Huxley, 1980 ; Feldman et al. 1987 ; van Hemert et al. 1993 ). Psychiatric screening (or ' case finding ') questionnaires, such as the General Health Questionnaire, have been advocated as an aid to case detection and clinical decision making (Goldberg, 1986) , and we recently reviewed their use (Gilbody et al. 2001 a) . Overall, we found no evidence for their effectiveness in improving quality of care. Measures of health related quality of life, such as the Short Form 36 (SF36) also identify psychosocial problems (Greenfield & Nelson, 1992) , since many contain items which measure ' psychological well-being ' (Ware & Sherbourne, 1992) and discriminate between groups of patients with and without clinically diagnosed depression (e.g. McHorney et al. 1993 ; McHorney & Ware, 1995) .
Health-related quality of life for those with disorders such as depression and schizophrenia is especially poor, and is on a par with chronic medical conditions such as rheumatoid arthritis and ischaemic heart disease (Wells et al. 1989 ; Orley et al. 1998 ). In the case of schizophrenia, impairments in health related quality of life are often unrelated to the number or severity of symptoms such as delusions and hallucinatory experiences (Becker et al. 1993 ; Anthony & Rogers, 1995) . Clinicians often underestimate the health related quality of life of patients, when compared to ratings made by patients themselves (Becker et al. 1993 ; Lehman, 1983 a, b ; Sainfort et al. 1996) . Empirical evidence shows that clinicians do not routinely measure HRQoL and needs using standardized measures .
For these reasons, recent mental health policy documents in England place great emphasis on the routine measurement of outcome and of patient needs (Secretary of State for Health, 1999) . However, the routine measurement of outcome has not been without its critics (Crombie & Davies, 1997) , and concerns have been raised that ' outcomes measures ' (including HRQoL and needs assessments) are un-interpretable, unwieldy and a bureaucratic hindrance to successful patient care. The measurement of outcome in the context of individual patient care is also not without cost, since instruments must be developed, administered (often by clinicians), coded, stored and retrieved. Similarly, there is a danger that outcome measurement triggers investigation or additional treatments, which are either of no benefit or harm to patients. There is a danger that the use of outcome measurement becomes a marketing ploy, in which measurement is used to demonstrate an institution's ' customer orientation ', while the results do not in fact inform the provision of care (Fitzpatrick, 1994) .
One way in which the usefulness of outcome measures in everyday care might be judged is by evaluating the degree to which their administration and feedback improves the outcome and quality of care. Previous (non-systematic) reviews of this question have been equivocal (Fitzpatrick, 1994) .
Aims and objectives
This review assesses systematically the best available evidence on the value of routine HRQoL and needs assessment in : (1) improving the psychological care and outcome of people being managed in non-psychiatric settings (such as primary care and the general hospital) ; and, (2) improving the quality of care and outcome of those with common mental disorders such as anxiety, depression and schizophrenia, being managed in specialist psychiatric settings.
METHOD
Search strategy
The following bibliographic databases were searched : MEDLINE (1966 MEDLINE ( -2000 ; EMBASE (1981 EMBASE ( -2000 ; CINAHL (1982 CINAHL ( -2000 ; PsycLIT (to 2000) ; Cochrane Controlled Trials Register (to 2000) ; Cochrane schizophrenia and depression, anxiety and neurosis group specialist registers (to 2001). The search strategy combined Medical Subject Heading (MeSH) terms relating to all forms of mental illness and utilized a comprehensive strategy for identifying research that relates to outcome and needs assessment (Brettle et al. 1998 ) (full search terms available from the authors).
Titles and abstracts from electronic searches were scrutinized and all potentially relevant articles were obtained. Reference lists were scrutinized for additional studies. In addition the following journals were hand searched : British Journal of Psychiatry (1976 Psychiatry ( -2000 ; American Journal of Psychiatry (1976 Psychiatry ( -2000 ; Archives of General Psychiatry (1976 Psychiatry ( -2000 ; Psychological Medicine (1976 Medicine ( -2000 ; Quality of Life Research (1993 Research ( -2000 ; Journal of Psychosomatic Research (1980 -2000 and, Medical Care (1976 -2000 .
Study inclusion criteria
Patients Studies were included if the subjects were : (1) patients in non-psychiatric settings, such as general hospitals or general practice ; or, (2) patients with psychiatric disorders being managed by specialist psychiatric services.
Studies relating to the following patient groups were excluded : (1) patients whose primary problem was one of substance abuse or who are managed in specialist substance abuse services ; (2) children and adolescents ; and, (3) those with learning disabilities or dementia.
Interventions
We included studies comparing the introduction and feedback of a routine form of HRQoL or needs assessment, with routine care. Routine care (the control\comparator condition) involved usual patient-doctor interaction, with nonstandardized history taking, investigation, referral, intervention and follow-up.
The active intervention involved the addition of a standardized HRQoL or needs assessment instrument to routine care ; with the information from the outcome assessment being fed back to the clinician or being incorporated into routine care procedures (such as out-patient assessment, hospital admission or routine discharge planning). Outcome could be assessed in both intervention and control conditions, but the active component in an intervention involved the feeding back of this information to the clinician.
Potentially relevant outcome assessment instruments included all measures of health related quality of life (HRQoL) or patient need, when either used in a psychiatric population or applied in a non-psychiatric setting with the aim of detecting and monitoring emotional problems. To be included as a measure of HRQoL or need, the instrument must address mental well-being, and at least two of the following domains outlined in an operational definition offered by Ware (1995) : physical health ; social functioning ; role functioning ; general perceptions of health and well-being ; cognitive capacity ; patient satisfaction.
Design
Randomized controlled clinical trials and quasirandomized trials were included.
Quality assessment
First, studies were judged according to accepted quality assessment criteria, using the Jadad scale (Jadad et al. 1996) , the criteria of Schulz et al. (1995) and Cochrane criteria (Mulrow & Oxman, 1999) . Particular attention was paid to the method of randomization, such that those studies that described themselves as randomized but did not describe an adequate method of randomization and concealment of allocation were distinguished from those that did.
Secondly, the unit of randomization was established. Cluster randomized studies were considered to be superior to non-cluster based studies, since the former avoid the inherent problem of cross contamination between patients seen by individual clinicians (Gilbody & Whitty, 2002) . For those studies in which the unit of randomization was by clinician or clinical population, rather than individual patients, evidence was sought that clustering had been incorporated into the analysis of the study by the authors (Ukoumunne et al. 1999) . Clusterbased studies that fail to incorporate the effect of intra-cluster correlation in their analysis are prone to a unit of analysis error, with a high probability of spurious positive results (type 1 errors) (Divine et al. 1992 ; Gilbody & Whitty, 2002) .
Outcomes
We sought data on primary psychological outcomes, including : the detection of psychiatric disorders, such as depression or anxiety ; initiation of treatment or referral for psychiatric disorders ; and, the outcome of psychiatric disorders and changes in aspects of health related quality of life. In addition, we sought data on : consulting behaviour and service use (both psychiatric and non-psychiatric) ; hospital status (e.g. discharge, readmission or length of stay) ; patient satisfaction with care and patient-doctor communication ; and, cost (direct and indirect).
We also identified process data on : clinician and patient perceptions of the usefulness or acceptability of measurement instruments ; and, self-reports of the use of outcome information in changing patient management.
Data synthesis
Interventions, settings and outcomes were too heterogeneous to apply formal meta-analytical pooling. Individual studies were reported separately, with their specific design features and results, in accordance with accepted guidelines (NHS Centre for Reviews and Dissemination, 2001) .
RESULTS
Nine studies using HRQoL instruments in nonpsychiatric settings were identified. Details of these studies are provided in Table 1 . We did not find any trials of the routine use of HRQoL and needs assessment measures in psychiatric settings.
Study design and quality
Seven studies (Goldsmith & Brodwick, 1989 ; Rubenstein et al. 1989 Rubenstein et al. , 1995 Calkins et al. 1994 ; Street et al. 1994 ; Wagner et al. 1997 ) investigated the use of generic health status measures : the SF36 , two studies ; the functional status questionnaire (FSQ) (Jette et al. 1986) , three studies ; the Dartmouth COOP ( Wasson et al. 1992 b) , one study ; and, the Sickness Impact Profile (SIP) (Bergner et al. 1981) , one study. One further study combined an anxiety questionnaire -the anxiety components of the Symptom Check List-90 (SCL-90) (Derogatis, 1994 ; Fifer et al. 1994) , with a generic health status questionnaire (the SF36) . One study (Kazis et al. 1990 ) used the disease specific Arthritis Impact Measurement Scale (AIMS) (Meenan, 1982) , which includes a series of depression and anxiety items. Instruments were generally administered in the waiting room by research assistants prior to consultation.
All studies were described as randomized, although method of randomization was rarely described in adequate detail. One study (Street (Goldsmith & Brodwick, 1989 ; Rubenstein et al. 1989 Rubenstein et al. , 1995 Calkins et al. 1994 ; Mazonson et al. 1994 ; Street et al. 1994) . None of these studies accounted for their clustering in their analysis of results.
The settings of the studies were : general medical\internal medicine out-patients (Rubenstein et al. 1989 (Rubenstein et al. , 1995 Calkins et al. 1994) ; general practice\family medicine (Goldsmith & Brodwick, 1989 ; Mazonson et al. 1994) ; rheumatology out-patients (Kazis et al. 1990 ) ; antenatal clinic (Street et al. 1994) ; neurology out-patients (Wagner et al. 1997) .
The active interventions broadly involved the feedback of instrument test results to the clinician -generally in the form of a sheet containing summary scores. Instruments were generally administered only once in each of the studies. In only four studies (Rubenstein et al. 1989 ; Kazis et al. 1990 ; Calkins et al. 1994 ; Mazonson et al. 1994) were assessments administered sequentially during the course of care or follow-up. In each case this was done at fixed points by research assistants, rather than at each clinical encounter.
In some studies (e.g. Mazonson et al. 1994 ; Rubenstein et al. 1995) , feedback of outcome results was combined with an active educational programme and the provision of standardized best practice guidelines on the management. For example, in the study by Mazonson et al. (1994) , the active educational programme involved sessions on the importance of deficits in health related quality of life and untreated anxiety, together with a description of the psychometric instruments and their interpretations. Results of profiles from three of their own patients were then discussed in detail and educational materials on the management of anxiety were provided in the form of audiotapes and articles. Additionally, a toll free telephone number was provided so that further questions could be answered by a study team physician.
Recognition of emotional problems and minor psychiatric disorders
Of the eight studies that employ broader measures of health related quality of life as their principle outcome measure (Goldsmith & Brodwick, 1989 ; Rubenstein et al. 1989 Rubenstein et al. , 1995 Kazis et al. 1990 ; Calkins et al. 1994 ; Street et al. 1994 ; Wagner et al. 1997) , four reported the effect of these measures in improving the overall rate of recognition of emotional problems (Rubenstein et al. 1989 ; Kazis et al. 1990 ; Calkins et al. 1994 ). Three of these four studies (Rubenstein et al. 1989 ; Kazis et al. 1990 ; Calkins et al. 1994) showed no differences in the rate of recognition of mental disorders at assessment or for any subscale of the FSQ or AIMS (including mental health) at 12 months.
In contrast, a later study by Rubenstein et al. (1995) reports that feedback of the FSQ increases both the rate of recognition of depression and anxiety. Symptoms of anxiety or depression were recorded by physicians in 30 % of case notes by clinicians receiving feedback, compared to 21 % among those not receiving feedback of results. This difference was of borderline significance (relative risk of detecting anxiety or depression following feedback l 1n42 ; 95 % CI, 0n98-2n08). The rate of recognition of anxiety problems was increased by the largest magnitude (13 % v. 4 %, relative risk of recognition of anxiety following feedback l 3n33 ; 95 % CI, 1n40-7n92), while the rate of recognition of depression was subject to a non-significant increase in recognition (23 % v. 20 %, relative risk of recognition of depression following feedback l 1n17 ; 95 % CI, 0n78-1n77). The major limitation of this study is, however, the fact that while it is a cluster randomized trial (clinicians are the unit of randomization), it is analysed according to individual patients without reference to intra-class correlation coefficients.
The study by Mazonson et al. (1994) specifically employed routine administration of the SCL-90 and the SF36, in combination with a physician education programme in order to increase the rate of recognition and improve the outcome of anxiety in primary care. This combined intervention increased the rate of recognition of anxiety disorders (defined as ' chart notations ') from 19 % in the control arm to 32 % in the intervention arm (relative risk of recognition of an anxiety disorder l 1n72 ; 95 % CI, 1n25-2n37). There was a marked increase in the rate of mental health referrals (10 % v.3% , relative risk of outside referral for an anxiety problem l 2n94 ; 95 % CI, 1n33-6n51). This increased rate of intervention was not accompanied by an increased rate of initiation of psychotropic prescriptions (13 % v.1 3% ) .
Subsequent outcome of emotional disorders
Of the two studies that showed a positive effect of routine outcomes measurement on the detection of mental disorders, the study by Mazonson et al. (1994) found no overall improvement in either total scores on the anxiety components of the SCL-90, or the mental health component of the SF36. The only positive effect reported was using an unpublished self-report scale of anxiety, used in conjunction with the SF36 and the SCL-90. The other positive study (Rubenstein et al. 1995) found a small, but statistically significant change in the mental health component of the FSQ (endpoint mean change difference l 4n5 points ; 95 % CI, 0n5-8n3, on a 100-point scale). Of the four component scales of the FSQ (activities of daily living ; mental health ; social activities ; work performance), mental health was the only scale to show a between group difference at the end of a 6-month study period.
Three further studies (Rubenstein et al. 1989 ; Kazis et al. 1990 ; Calkins et al. 1994) showed no overall between group difference in any score on the disease specific AIMS or generic FSQ, including anxiety and depression scores at 12-month follow-up.
Consulting behaviour
Only two studies (Goldsmith et al. 1989 ; examined the effect of feedback on consulting behaviour, and found no effect on number of physician visits or resource use.
Patient satisfaction with care and patient-doctor communication
The study by Street et al. (1994) examined the effect of the administration and feedback of the SF36 on patient satisfaction and communication in the antenatal clinic. Their survey showed that patients generally wanted to be asked about ' health status overall ' and listed the components of the health status about which they wanted to be asked. All patients wanted to be asked about ' pain ' and ' perceptions of health ', fewer expressed a preference to be asked about ' social functioning ' and ' mental health '. The administration of the SF36 increased the patients' satisfaction with care, but feedback of these instruments did not affect the degree to which physicians were perceived as having asked about ' health status overall '. No data were presented on the degree to which feedback of SF36 results increased the detection or discussion of mental health problems.
The study by Mazonson et al. (1994) included a patient interview of those who received treatment for anxiety. Feedback seemed to encourage clinicians to be more proactive in raising the problem of anxiety and need for treatment. Among those who had their scores fed back and received treatment, 67 % reported that their physicians had been proactive in initiating treatment, whereas among those whose scores were not fed back, only 33 % reported that the physicians had taken the first step in suggesting treatment.
The study by Wagner et al. (1997) showed that physicians generally felt that data from the SF36 were useful in guiding clinical practice, but this was not reflected in any between group differences in patient satisfaction with their care. Interestingly, the study by Goldsmith et al. (1989) showed that the administration of the SIP was felt to be unhelpful in the context of routine consultations, since the instrument was perceived as being over long and difficult to assimilate into routine decision making. The results of the SIP were discussed in less than one-third of consultations.
Costs
No study examined the costs and resource use associated with routine outcome measurement.
DISCUSSION
Main findings of the review
The main findings of this systematic review are two-fold. First, the evidence to support the routine use of HRQoL instruments in improving the quality of care and mental well-being of nonpsychiatric populations is largely negative. Secondly, there is no randomized evidence to support the routine use of HRQoL or needs assessment instruments in improving the quality of care or outcome of patients with recognized psychiatric disorders being managed in specialist mental healthcare settings. These two findings will now be discussed in turn.
HRQoL instruments to improve the psychological care and outcome in nonpsychiatric settings Mental well-being forms a core component of health related quality of life, as defined by many authors (Bergner & Rothman, 1987 ; Walker & Rosser, 1993 ; Ware, 1995 ; Bowling, 1997) . The application of instruments designed to measure HRQoL, which include component scales of depression and anxiety, has not generally been shown to improve mental well-being or to increase the rate at which clinical disorders are recognized. The only two positive studies in the present review involved an intensive clinician educational component, targeting the importance, recognition and treatment of anxiety , or were of borderline statistical significance in an inappropriately analysed study (Rubenstein et al. 1995) .
The results of the present review should be considered alongside the results of our previous review (Gilbody et al. 2001 a) , which found that specific mood questionnaires (such as the General Health Questionnaire and Zung Depression Inventory) have little impact on the rate of detection of mood disorders when administered routinely to all patients. The major reasons for the ineffectiveness of these instruments on routine clinical care are likely to relate to : the impracticality of the instruments ; clinicians lack of familiarity with their results ; and the difficulty of integrating the results of such instruments into routine clinical decision making (Deyo & Patrick, 1989) .
It is possible that benefit cannot and will never be demonstrated for the routine use of HRQoL measures in individual patient decision making, since this is a purpose for which the instruments were not designed. In particular, some critics have suggested that the psychometric properties of generic health status measures are such that their scores are un-interpretable at an individual patient level (McHorney & Tarlov, 1994) . Generic outcomes measures are essentially designed to evaluate healthcare and to identify need at a population level (Ware, 1995) , and extrapolation of use beyond this may be unwise (Dunn, 1996) .
Routine measurement of outcome in psychiatric settings
Given the centrality of routine outcome measurement, including the measurement of HRQoL and patient needs, in recent mental health policy, it is perhaps surprising that there is no randomized evidence to support its adoption.
There are a number of candidate measures and instruments such as the Health of the Nation Scale (HoNOS) (Wing, 1994) and the Camberwell Assessment of Need (CAN) (Phelan et al. 1995) , which were developed for use in routine care settings, and HRQoL measures such as the SF36, which have been shown to be both reliable and valid in depression (Coulehan et al. 1997 ) and in schizophrenia (Russo et al. 1998) .
Outcome measurement and needs assessment among those cared for by specialist psychiatric services represent a health technology, which consumes resources -including clinician time and administrative support. In order to justify the collection of these data on a routine basis some benefit in terms of patient care and outcome must be demonstrated. National mental health research and policy initiatives, such as the development and adoption of the HoNOS (Wing, 1994) are dependent upon individual clinicians collecting data in routine practice (Stein, 1999) . For clinicians to be willing to collect such data for each and every patient, there must be some value in terms of improving the management of the individual patient. A case study of the implementation of the HoNOS shows that clinicians find it to be of limited value in care planning and day-to-day clinical practice (Sharma et al. 1999) ; the authors noted that the HoNOS fell from use after research funding had ceased.
This observation would have come as no surprise to Alvan Feinstein (1967) who more than 30 years ago wrote :
The care of the patient is the ultimate specific act that characterises the clinician, and any classificatory system that cannot help in that will fail to gain acceptance.
Given these findings, the effectiveness of the routine use of outcomes measures in specialist psychiatric settings cannot be assumed. There remains an important gap in the research literature, and randomized evaluations of the effectiveness of routinely administered HRQoL and needs assessment tools should precede their widespread introduction. This review will also be published and updated in line with emerging evidence on the Cochrane Electronic Library. S. G. was supported by the UK Medical Research Council Health Services Research Training Fellowship programme.
